Market capitalization | CHF3.93b |
Enterprise Value | CHF4.64b |
P/E (TTM) P/E ratio | 21.49 |
EV/FCF (TTM) EV/FCF | 20.36 |
EV/Sales (TTM) EV/Sales | 1.18 |
P/S ratio (TTM) P/S ratio | 1.00 |
P/B ratio (TTM) P/B ratio | 2.54 |
Dividend yield | 2.92% |
Last dividend (FY24) | CHF2.30 |
As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.
6 Analysts have issued a Galenica forecast:
6 Analysts have issued a Galenica forecast:
Dec '24 |
+/-
%
|
||
Revenue | 3,921 3,921 |
5%
5%
|
|
Gross Profit | 385 385 |
2%
2%
|
|
EBITDA | 318 318 |
8%
8%
|
EBIT (Operating Income) EBIT | 208 208 |
8%
8%
|
Net Profit | 183 183 |
36%
36%
|
In millions CHF.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Galenica AG engages as a health care provider in Switzerland. It operates through the following segments: Health & Beauty and Services. The Health and Beauty segment comprises the two business sectors Retail; and Products and Brands. The Services segment offers pharmaceutical and healthcare companies pre-wholesale services, from storage and distribution of products in Switzerland to debt collection. The company was founded on 1927 and is headquartered in Bern, Switzerland.
Head office | Switzerland |
CEO | Marc Werner |
Employees | 6,119 |
Founded | 1927 |
Website | www.galenica.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.